Latest news with #SP500
Yahoo
2 hours ago
- Business
- Yahoo
Stock Index Futures Tread Water With All Eyes on Key U.S. Jobs Report
September S&P 500 E-Mini futures (ESU25) are up +0.03%, and September Nasdaq 100 E-Mini futures (NQU25) are up +0.08% this morning as investors sit on their hands ahead of the all-important U.S. payrolls report that will offer fresh insight into the labor market and the path of interest rates. Investors are also keeping an eye out for any updates on trade deals. Reuters reported that U.S. and India trade negotiators were working on Wednesday to secure a tariff-reducing deal ahead of the July 9th deadline, though disagreements over U.S. dairy and agriculture remained unsettled. Also, European Union trade chief Maros Sefcovic is set to meet with his counterparts today in Washington as the bloc scrambles to reach a deal before the July 9th deadline. Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025? Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is MicroStrategy Stock a Buy, Sell, or Hold for July 2025? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! U.S. President Donald Trump's massive tax and spending bill remains in focus as well. The Republican-controlled U.S. House of Representatives on Thursday advanced President Trump's tax bill, a procedural step that paves the way for potential passage of the legislation in a vote expected later in the day. Once the bill clears the House again, it will head to Trump's desk, where he has long awaited the opportunity to sign it into law. The U.S. stock markets will close early at 1 p.m. Eastern Time today and remain closed on Friday for the Independence Day holiday. In yesterday's trading session, Wall Street's major indices closed mixed. Tesla (TSLA) advanced over +4% after the electric vehicle company reported better-than-feared Q2 deliveries. Also, chip stocks gained ground, with NXP Semiconductors N.V. (NXPI) and ON Semiconductor (ON) rising more than +4%. In addition, Nike (NKE) climbed over +4% and was the top percentage gainer on the Dow after President Trump said the U.S. reached a trade deal with Vietnam. On the bearish side, Centene (CNC) plummeted more than -40% and was the top percentage loser on the S&P 500 after the health insurer withdrew its full-year profit guidance. The ADP National Employment report released on Wednesday showed that U.S. private nonfarm payrolls unexpectedly fell -33K in June, weaker than expectations of +99K and the first decline in 2-1/4 years. 'The ADP report increased the odds of a downside surprise in Thursday's nonfarm payroll release,' said Jeff Roach at LPL Research. 'Investor jitters could be a catalyst for a drop in yields [today] if the jobs report is weaker than expected. I expect a weaker-than-consensus report, increasing the odds the Fed cuts three times this year.' Traders increased bets on at least two rate cuts this year following the weak ADP data, with the first expected in September. Meanwhile, U.S. rate futures have priced in a 74.7% chance of no rate change and a 25.3% chance of a 25 basis point rate cut at the conclusion of the Fed's July meeting. Today, all eyes are focused on the U.S. monthly payroll report, which is set to be released in a couple of hours. Economists, on average, forecast that June Nonfarm Payrolls will come in at 111K, compared to the May figure of 139K. A survey conducted by 22V Research revealed that investors are paying closer attention to the key jobs report than usual this time and are anticipating a weaker print. Among the respondents, 44% expect the data to be 'mixed/negligible,' 41% anticipate a 'risk-off' reaction, and only 15% expect a 'risk-on' response. Investors will also focus on U.S. Average Hourly Earnings data. Economists expect June figures to be +0.3% m/m and +3.9% y/y, compared to the previous numbers of +0.4% m/m and +3.9% y/y. The U.S. Unemployment Rate will be reported today. Economists forecast that this figure will creep up a tick to 4.3% in June from 4.2% in the prior month. The U.S. ISM Non-Manufacturing PMI and S&P Global Services PMI will be closely monitored today. Economists expect the June ISM services index to be 50.8 and the S&P Global services PMI to be 53.1, compared to the previous values of 49.9 and 53.7, respectively. U.S. Factory Orders data will come in today. Economists foresee the May figure jumping +8.1% m/m, compared to -3.7% m/m in April. U.S. Trade Balance data will be released today. Economists anticipate the trade deficit will widen to -$69.90B in May from -$61.60B in April. U.S. Initial Jobless Claims data will be released today as well. Economists expect this figure to be 240K, compared to last week's number of 236K. In addition, market participants will be looking toward a speech from Atlanta Fed President Raphael Bostic. In the bond market, the yield on the benchmark 10-year U.S. Treasury note is at 4.256%, down -0.79%. The Euro Stoxx 50 Index is down -0.05% this morning as investors continue to monitor trade developments and cautiously await the key U.S. jobs report. The benchmark index initially moved higher, buoyed by the U.S.-Vietnam trade deal and news that the U.S. lifted export restrictions to China for chip design software makers and ethane producers. However, trade optimism was tempered by caution ahead of the release of the all-important monthly U.S. jobs report. A survey released on Thursday showed that the Eurozone's dominant services sector returned to growth in June after a brief contraction in May, though the pace remained modest as demand stayed weak despite improving business confidence. Meanwhile, European Union trade chief Maros Sefcovic is set to meet with his counterparts today in Washington as the bloc scrambles to reach a deal before the July 9th deadline. In corporate news, Redcare Pharmacy NV ( rose over +3% after the German online drug retailer reported solid preliminary Q2 revenue and confirmed its full-year guidance. Eurozone's Composite PMI and Eurozone's Services PMI data were released today. Eurozone's June Composite PMI stood at 50.6, stronger than expectations of 50.2. Eurozone's June Services PMI arrived at 50.5, stronger than expectations of 50.0. Asian stock markets today closed in the green. China's Shanghai Composite Index (SHCOMP) closed up +0.18%, and Japan's Nikkei 225 Stock Index (NIK) closed up +0.06%. China's Shanghai Composite Index closed slightly higher today as investors digested the latest developments in U.S.-China trade relations and kept an eye on trade negotiations between the U.S. and other nations. Healthcare stocks led the gains on Thursday after Beijing increased policy support for the nation's innovative drug sector. Semiconductor stocks were little changed following reports that the U.S. lifted some curbs on exports of chip-design software to China. The U.S. also gave the green light to resume ethane exports to China on Wednesday, signaling that the U.S.-China trade truce was on track. At the same time, China's commerce ministry said on Thursday that it is evaluating the trade deal between the U.S. and Vietnam and will defend its own rights and interests if necessary. Meanwhile, a private sector survey released on Thursday showed that China's services activity grew at the slowest pace in nine months in June, as demand softened and new export orders fell amid a fragile trade truce with the U.S. Still, surveyed companies stayed optimistic about the economic outlook, with the index for future output expectations holding steady from the prior month. In other news, a major Chinese Communist Party publication called for stricter measures against competition that triggers price wars and compresses profits across multiple industries, criticizing large corporations and local governments for engaging in unfair practices. In corporate news, Alibaba slid nearly -3% in Hong Kong after the e-commerce giant announced a 50 billion yuan ($6.98 billion) subsidy program aimed at supporting merchants and customers. Investor focus is now squarely on the July Politburo meeting and the upcoming half-year earnings season. The Chinese June Caixin Services PMI arrived at 50.6, weaker than expectations of 51.0. Japan's Nikkei 225 Stock Index closed slightly higher today as investor sentiment was subdued amid uncertainty over a trade deal with the U.S. Automobile and chip stocks gained ground on Thursday. The benchmark index spent most of the session in negative territory before pushing higher at the close. A private sector survey released on Thursday showed that Japan's service sector activity grew at a slightly quicker pace in June, with business confidence rising to a four-month high. U.S. President Donald Trump has recently intensified pressure on Japan, describing negotiations as 'really hard' and threatening to hike tariffs on Japanese imports to '30%, 35% or whatever the number is that we determine.' Japanese Prime Minister Shigeru Ishiba stated on Wednesday that he remains committed to defending Japan's national interests, while chief trade negotiator Ryosei Akazawa was reportedly arranging his eighth visit to the U.S. as soon as this weekend. Deputy Chief Cabinet Secretary Kazuhiko Aoki said that the country will continue to pursue a win-win trade deal with the U.S. Meanwhile, Bank of Japan policy board member Hajime Takata said on Thursday that the central bank should be prepared to resume policy tightening if trade talks with the U.S. progress, reaffirming that the bank is still aiming to raise interest rates. 'I believe that the bank is currently only pausing its policy interest rate hike cycle and should continue to make a gear shift after a certain period of 'wait-and-see,'' Takata said. In other news, data from Japan's finance ministry showed that foreign investors purchased a net 651.3 billion yen ($4.53 billion) worth of Japanese equities in the week to June 28th, driven by easing Middle East tensions and growing optimism over a rally in technology stocks. The Nikkei Volatility Index, which takes into account the implied volatility of Nikkei 225 options, closed up +1.65% to 25.83. The Japanese June au Jibun Bank Services PMI came in at 51.7, stronger than expectations of 51.5. Pre-Market U.S. Stock Movers Datadog (DDOG) surged over +10% in pre-market trading after S&P Dow Jones Indices announced that the stock would be added to the S&P 500 index next week. Synopsys (SNPS) and Cadence Design Systems (CDNS) climbed over +6% in pre-market trading after the U.S. lifted export restrictions on chip design software to China. Tripadvisor (TRIP) gained more than +6% in pre-market trading after the Wall Street Journal reported that activist investor Starboard Value had built a more than 9% stake in the online travel company. Meta Platforms (META) rose about +0.5% in pre-market trading after Needham upgraded the stock to Hold from Underperform. FedEx (FDX) advanced over +1% in pre-market trading after BNP Paribas Exane upgraded the stock to Outperform from Underperform with a price target of $270. You can see more pre-market stock movers here Today's U.S. Earnings Spotlight: Thursday - July 3rd N/A. On the date of publication, Oleksandr Pylypenko did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
5 hours ago
- Business
- Yahoo
UnitedHealth Stock Is One of the Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?
Wall Street is cheering fresh highs as the S&P 500 Index ($SPX) wraps a solid second quarter, closing June 2025 strong. The rally has been powered by cooling inflation, resilient earnings, and fading tariff concerns after April's policy shock. Just three months back, the market briefly dipped toward bear territory amid geopolitical tensions, China's AI push, tariff fears, and fiscal uncertainty, keeping investors on edge about the rebound's staying power. Despite the S&P rallying over 28% from its April lows of $4,835, the bull run has still left many big names behind. Nearly a third of the index's stocks still ended the first half of 2025 in the red. UnitedHealth (UNH), a giant in health insurance and managed care services, has plunged 39% so far in 2025. UNH stock has been hit by soaring Medicare Advantage costs, a probe into Medicare fraud, and a sudden CEO exit, making it the index's fourth-worst performer. Michael Saylor Says 'You'll Wish You'd Bought More' Bitcoin as MicroStrategy Doubles Down Is Microsoft Stock About to Go Nuclear? Is Super Micro Computer Stock a Buy, Sell, or Hold for July 2025? Tired of missing midday reversals? The FREE Barchart Brief newsletter keeps you in the know. Sign up now! While UNH is at five-year lows, a 1.8% five-day bounce hints at some life. With the dividend-paying stock halved and trading at a compelling valuation, is this a classic 'buy the dip' setup? Or a moment for caution despite the allure of value and yield? Founded in 1977, UnitedHealth has grown into a $295 billion healthcare heavyweight. With its deep roots in health insurance and care services, the company runs on two powerhouse engines: UnitedHealthcare and Optum. UnitedHealthcare handles the insurance side, offering plans that serve over 50 million people. It's the backbone, giving the company scale, reach, and reliable revenue. But it's Optum that brings the spark, driving growth through data, tech, and pharmacy solutions. From analytics to care delivery, Optum's strategy pushes innovation across the system. Together, these segments give the company its edge in a complex healthcare landscape. UNH stock has been in free fall in 2025, hitting a low of $248.88 in May. Over the past 52 weeks, the stock has declined 38%, trailing far behind the broader S&P's surge of 13%. However, UNH stock is rebounding, up 1% over the past month. UnitedHealth's downfall in 2025 was not just a single bad headline. It was a chain reaction that started fast and spiraled hard. It kicked off on April 17, when the company shocked the Street by slashing its full-year earnings forecast. This was because a flood of higher-acuity Medicare Advantage patients drove costs far beyond expectations, exposing just how outdated and fragile their forecasting models had become. Then May hit like a wrecking ball. CEO Andrew Witty abruptly resigned, raising eyebrows amid growing pressure. Days later, reports surfaced of a U.S. Department of Justice investigation into alleged Medicare fraud. By mid-May, the stock had crashed, hitting five-year lows. Just when it seemed the damage was done, more scandal dropped with accusations of UnitedHealth secretly paying nursing homes to avoid costly hospital transfers. Even insider buying gave only a brief lift to UNH. In a short span, UnitedHealth went from a rock-solid name to a cautionary tale unraveling in real time. After its brutal springtime plunge, UNH stock is priced at 14 times forward earnings and 0.7 times sales, trading in bargain territory. Those multiples sit well below both the sector medians and its own five-year averages, catching the eye of value hunters sniffing out a possible rebound. Despite the stock's decline, UnitedHealth has signaled some confidence where it counts: dividends. In June, the company hiked its quarterly payout by 5.2% to $2.21, marking 15 consecutive years of increases. Paid out on June 24, the hike pushed its annual yield near 2.6%. On April 17, UnitedHealth reported Q1 2025 earnings, and it wasn't the kind of update Wall Street wanted to hear. Revenue climbed 9.8% year-over-year (YOY) to $109.6 billion but still came in shy of expectations. Adjusted EPS rose 4.2% to $7.20 yet missed the estimated mark of $7.27. UnitedHealthcare, the insurance arm, posted a solid 12.2% revenue gain to $84.6 billion. Meanwhile, Optum saw more modest growth of 4.6% to $63.9 billion, with Optum Rx doing the heavy lifting. Still, rising costs loomed large. Total operating expenses surged 9.4% annually to $100.5 billion. On the brighter side, the company exited the quarter with $34.3 billion in cash and short-term investments and generated $5.5 billion in operating cash flow. Shareholders weren't left in the cold either, with over $5 billion returned through buybacks and dividends. UnitedHealth's steep selloff wasn't just about Q1 results. It was the guidance cut that really rattled sentiment. Management slashed its 2025 adjusted EPS outlook to between $26 and $26.50, down from the initially forecast range of $29.50 to $30 in December 2024 and below fiscal 2024 adjusted EPS of $27.66. Surging Medicare Advantage costs and shifts in Optum's patient mix have taken a real bite. Now, all eyes are on the fiscal Q2 report, expected to be released on July 29 before the market opens. Analysts forecast the Q2 bottom line to be around $5.08 per share, down 25% YOY. Looking to fiscal 2025, adjusted EPS is expected to decline 20% annually to $22.07, then surge by 15% to $25.39 in fiscal 2026. Last Wednesday, UBS reiterated its 'Buy' rating on UNH stock but trimmed the price target to $385 from $400. The cut followed CEO Stephen Hemsley's cautious tone at the June 2 meeting, hinting at more conservative 2025 guidance. UBS anticipates fiscal 2025 EPS closer to $20, down from the earlier $22.50 consensus. Margins were also revised, with Medicare Advantage trimmed to 1.5% and Optum Health lowered to 4.5%. Despite the recent shakeups, Wall Street hasn't completely hit the panic button yet. Last month, UnitedHealth shook things up by axing broker commissions on select Medicare Advantage plans — a move aimed at trimming the cost that forced it to yank full-year guidance. Hightower Chief Investment Strategist Stephanie Link called it a smart pivot, saying the same issue 'got them in trouble' to begin with. Link is bracing for short-term volatility but stays bullish long-term, calling UNH stock 'too cheap' for a top-tier name in the industry. There's still optimism in the air, but with a touch of caution. UNH stock has a 'Moderate Buy' consensus overall, down from a consensus 'Strong Buy' rating a month ago. Of the 24 analysts covering the stock, 15 advise a 'Strong Buy,' two suggest a 'Moderate Buy,' and seven analysts play it safe with a 'Hold.' The mean price target of $363.43 implies shares could rise as much as 18%. The Street-high target of $440, way below this year's highs, signals that UNH has an upside potential of 43% from current levels. The U.S. healthcare industry, despite constant political firestorms, is built to endure. For years, UnitedHealth has stood as its crown jewel. Defensive, dividend-paying, and shock-resistant, it has been the kind of stock long-term investors can count on. But 2025 has shattered that illusion. While the broader market climbs to record highs, UnitedHealth's dramatic plunge reminds us that even giants can stumble hard. Sure, UNH stock now trades at a discount, offering an attractive dividend yield. Insiders are buying shares, and UnitedHealth still commands significant market share and robust cash flow. But is this really a 'buy the dip' moment? It's probably a bet that management can steady the ship, and the storm eventually clears. Until then, UnitedHealth sits in a gray zone between legacy and uncertainty, where long-term promise collides with short-term pain. Investors should exercise caution before jumping in. On the date of publication, Sristi Suman Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 hours ago
- Business
- Yahoo
2 S&P 500 Stocks with Promising Prospects and 1 to Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn't mean every stock is worth owning. Some companies face significant challenges, whether it's stagnating growth, heavy debt, or disruptive new competitors. Some large-cap stocks are past their peak, and StockStory is here to help you separate the winners from the laggards. Keeping that in mind, here are two S&P 500 stocks that could deliver good returns and one best left off your watchlist. Market Cap: $21.92 billion With over 600 million tests performed annually and involvement in 90% of FDA-approved drugs in 2023, Labcorp (NYSE:LH) provides laboratory testing services and drug development solutions to doctors, hospitals, pharmaceutical companies, and patients worldwide. Why Does LH Fall Short? Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy Efficiency has decreased over the last five years as its adjusted operating margin fell by 13.3 percentage points Waning returns on capital imply its previous profit engines are losing steam At $261.89 per share, Labcorp trades at 15.9x forward P/E. Check out our free in-depth research report to learn more about why LH doesn't pass our bar. Market Cap: $75.19 billion Formed after the 1928 combination between toothpaste maker Colgate and soap maker Palmolive-Peet, Colgate-Palmolive (NYSE:CL) is a consumer products company that focuses on personal, household, and pet products. Why Could CL Be a Winner? Large revenue base of $19.95 billion and strong customer awareness make retailers more likely to stock its products Strong free cash flow margin of 16.3% enables it to reinvest or return capital consistently, and its rising cash conversion increases its margin of safety Stellar returns on capital showcase management's ability to surface highly profitable business ventures, and its returns are climbing as it finds even more attractive growth opportunities Colgate-Palmolive's stock price of $92.78 implies a valuation ratio of 24.7x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it's free. Market Cap: $203.2 billion With roots dating back to 1891 and a portfolio that includes the blockbuster cancer immunotherapy Keytruda, Merck (NYSE:MRK) develops and sells prescription medicines, vaccines, and animal health products across oncology, infectious diseases, cardiovascular, and other therapeutic areas. Why Do We Like MRK? Massive revenue base of $63.92 billion in a highly regulated sector makes the company difficult to replace, giving it meaningful negotiating power Free cash flow margin increased by 10.7 percentage points over the last five years, giving the company more capital to invest or return to shareholders Industry-leading 15.6% return on capital demonstrates management's skill in finding high-return investments Merck is trading at $80.93 per share, or 8.9x forward P/E. Is now the right time to buy? Find out in our full research report, it's free. Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Sign in to access your portfolio
Yahoo
7 hours ago
- Business
- Yahoo
US Stock Futures Drop on Latest Trump Tariff Salvo: Markets Wrap
(Bloomberg) -- US stock futures retreated Friday after the latest threat on tariffs from the Trump administration took the shine off a record rally for the S&P 500. Foreign Buyers Swoop on Cape Town Homes, Pricing Out Locals NYC Commutes Resume After Midtown Bus Terminal Crash Chaos Massachusetts to Follow NYC in Making Landlords Pay Broker Fees Struggling Downtowns Are Looking to Lure New Crowds What Gothenburg Got Out of Congestion Pricing Contracts for the US benchmark fell 0.6% after the gauge ended the trading week at a fresh all-time high, with payrolls data affirming the economy's resilience. Trump dialed up trade tensions after Thursday's close, warning partners he may start setting levies of as much as 70% unilaterally as soon as today. Europe's Stoxx 600 dropped 0.7%, with trade-exposed miners and automakers among the biggest decliners. Asian stocks also fell. Gold rose 0.3% as investors sought havens. The dollar dipped. US stocks and Treasury markets were closed for the July 4 holiday. Equity markets have rallied sharply since April's tariff-related volatility. Still, some investors remain cautious as uncertainties surrounding the trade war and its potential impact on the US economy and corporate earnings persist. 'There's a little bit of doubt of creeping in, especially after the bump up this week,' said Neil Wilson, investor strategist at Saxo UK. 'Today's a good day to take a little bit of risk off. But I don't think there's a fundamental shift, it's all on the margins at the moment.' What Markets Live Strategists Say: 'It would take a shocking set of trade outcomes to overwhelm the slew of good news we've recently had. All the more so, given that the bullishness of institutional investors has been tempered by constant threats, leaving them relatively underexposed to a market at record highs.' — Mark Cudmore, Markets Live Executive Editor The S&P 500's surge has put it on the verge of triggering a sell signal, according to Michael Hartnett of Bank of America Corp. The strategist advised that investors consider trimming their holdings once the index climbs beyond 6,300, a level just 0.3% above where it closed on Thursday. He also reiterated that bubble risks are mounting into the summer, especially following the House's approval of a $3.4 trillion fiscal package featuring tax cuts. 'Overbought markets can stay overbought as greed is harder to conquer than fear,' Hartnett wrote in a note. European bond markets firmed on Friday, but UK gilts made little headway after a selloff on Wednesday that was driven by fiscal concerns. The yield on 10-year UK government debt was little changed at 4.53%, compared with 4.45% at the close on Tuesday. The pound was flat. In signs of diplomatic and trade tensions escalating between China and the European Union, Beijing said it intends to cancel part of a two-day summit with EU leaders planned for later this month. China also imposed anti-dumping duties on European brandy for five years, while exempting major cognac makers that meet a price commitment. Remy Cointreau SA briefly slipped before trading higher. Pernod Ricard SA pared losses. In commodities, oil dropped in the lead-up to an OPEC+ meeting that's set to deliver another oversized production hike, threatening to swell a glut forecast for later this year. Corporate Highlights: Air France-KLM will initiate the process of raising its minority stake in Scandinavian airline SAS AB to 60.5%, as it looks to extend consolidation in European aviation. India's regulator has temporarily barred Jane Street Group LLC from accessing the local securities market, dealing a severe hit to the US firm that allegedly made $4.3 billion in trading gains in the South Asian nation in less than two years. French train maker Alstom SA has won a €2 billion ($2.4 billion) order from New York's Metropolitan Transportation Authority, which is in the process of modernizing its fleet. A European insurance group backed by Apollo Global Management Inc. offered to acquire a specialist UK insurer that's partly owned by a company controlled by South African billionaire Johann Rupert for about £5.7 billion ($7.8 billion). Some of the main moves in markets: Stocks The Stoxx Europe 600 fell 0.7% as of 10:55 a.m. London time S&P 500 futures fell 0.6% Nasdaq 100 futures fell 0.5% Futures on the Dow Jones Industrial Average fell 0.5% The MSCI Asia Pacific Index fell 0.3% The MSCI Emerging Markets Index fell 0.5% Currencies The Bloomberg Dollar Spot Index fell 0.2% The euro rose 0.2% to $1.1779 The Japanese yen rose 0.4% to 144.33 per dollar The offshore yuan rose 0.1% to 7.1629 per dollar The British pound was little changed at $1.3658 Cryptocurrencies Bitcoin fell 0.9% to $108,994.31 Ether fell 1.9% to $2,552.14 Bonds The yield on 10-year Treasuries was little changed at 4.35% Germany's 10-year yield declined three basis points to 2.59% Britain's 10-year yield was little changed at 4.53% Commodities Brent crude fell 1% to $68.09 a barrel Spot gold rose 0.3% to $3,335.67 an ounce This story was produced with the assistance of Bloomberg Automation. SNAP Cuts in Big Tax Bill Will Hit a Lot of Trump Voters Too America's Top Consumer-Sentiment Economist Is Worried How to Steal a House China's Homegrown Jewelry Superstar For Brazil's Criminals, Coffee Beans Are the Target ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
8 hours ago
- Business
- Bloomberg
S&P 500 Rally Brings a Sell Signal Into View
Investors in the US stock market have to be feeling pretty good as they take a break for the July 4 holiday: The S&P 500 finished the shortened week at yet another record, bolstered by a jobs report that shows an economy that's slowing but still solid. Now comes Bank of America's Michael Hartnett to spoil the party. The rally has brought the stock market to within striking distance of a sell signal, the investment strategist says in a report.
